Morgan Stanley Processa Pharmaceuticals, Inc. Transaction History

Morgan Stanley

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Oct 27, 2022	BUY	$1.68 - $3.55 $82,236 - $173,772	48,950 Added 4895000.0%	48,951 $138,000
Q2 2022 Aug 15, 2022	BUY	$1.68 - $3.55 $82,236 - $173,772	48,950 Added 4895000.0%	48,951 $138,000
Q1 2022 Oct 27, 2022	SELL	$3.01 - $5.21 $147,339 - $255,029	-48,950 Reduced 100.0%	1 $0
Q1 2022 May 13, 2022	BUY	$3.01 - $5.21 $3 - $5	1 New	1 $0
Q4 2021 Feb 14, 2022	SELL	$4.03 - $8.42 $274 - $572	-68 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.28 - $8.61 $359 - $585	68 New	68 $1,000

Ticker PCSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,856,200
Market Cap $14.4M
Description
Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase 2B clinical trials for the treatment of ulcerative and non-ulcerative necrobiosi...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.